Dashboard
Manage Tickers

CVMCEL SCI CORP

NYSE cel-sci.com


$ 1.21 $ 0.02 (1.67 %)    

Friday, 09-Aug-2024 15:57:59 EDT
CLICK TO SEE RELEVANT LITIGATION UPDATES
Y-mAbs Therapeutics, Inc. | YMAB | Take Action!
QQQ $ 450.22 $ 2.34 (0.52 %)
DIA $ 395.16 $ 0.63 (0.16 %)
SPY $ 532.81 $ 2.34 (0.44 %)
TLT $ 96.28 $ 0.94 (0.99 %)
GLD $ 224.54 $ 0.55 (0.25 %)
$ 1.22
$ 1.20 x 100
-- x --
-- - --
$ 1.02 - $ 3.23
242,949
na
66.08M
$ 0.93
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 05-15-2024 03-31-2024 10-Q
2 02-14-2024 12-31-2023 10-Q
3 12-21-2023 09-30-2023 10-K
4 08-10-2023 06-30-2023 10-Q
5 05-12-2023 03-31-2023 10-Q
6 02-14-2023 12-31-2022 10-Q
7 12-27-2022 09-30-2022 10-K
8 08-12-2022 06-30-2022 10-Q
9 05-13-2022 03-31-2022 10-Q
10 02-11-2022 12-31-2021 10-Q
11 12-21-2021 09-30-2021 10-K
12 08-13-2021 06-30-2021 10-Q
13 05-17-2021 03-31-2021 10-Q
14 02-12-2021 12-31-2020 10-Q
15 12-29-2020 09-30-2020 10-K
16 08-10-2020 06-30-2020 10-Q
17 05-08-2020 03-31-2020 10-Q
18 02-10-2020 12-31-2019 10-Q
19 12-16-2019 09-30-2019 10-K
20 08-14-2019 06-30-2019 10-Q
21 05-14-2019 03-31-2019 10-Q
22 02-14-2019 12-31-2018 10-Q
23 12-19-2018 09-30-2018 10-K
24 08-14-2018 06-30-2018 10-Q
25 05-15-2018 03-31-2018 10-Q
26 02-12-2018 12-31-2017 10-Q
27 12-29-2017 09-30-2017 10-K
28 08-09-2017 06-30-2017 10-Q
29 05-10-2017 03-31-2017 10-Q
30 02-09-2017 12-31-2016 10-Q
31 12-14-2016 09-30-2016 10-K
32 08-09-2016 06-30-2016 10-Q
33 05-10-2016 03-31-2016 10-Q
34 02-09-2016 12-31-2015 10-Q
35 12-11-2015 09-30-2015 10-K
36 08-07-2015 06-30-2015 10-Q
37 05-08-2015 03-31-2015 10-Q
38 02-06-2015 12-31-2014 10-Q
39 12-23-2014 09-30-2014 10-K
40 08-08-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

why-saia-shares-are-trading-lower-here-are-other-stocks-moving-in-fridays-mid-day-session
Why Saia Shares Are Trading Lower? Here Ar...
07/26/2024 17:25:58

cel-sci-shares-resume-trade
CEL-SCI Shares Resume Trade
07/26/2024 16:15:25

cel-sci-shares-halted-on-code-news-pending
CEL-SCI Shares Halted On Code News Pending
07/26/2024 15:59:52

cel-sci-prices-10845m-best-efforts-offering-of-10845m-shares-and-pre-funded-warrants-at-a-price-of-1share
CEL-SCI Prices $10.845M Best-Efforts Offer...
07/26/2024 15:52:51

CEL-SCI Corporation ("CEL-SCI" or the "Company") (NYSE: CVM), a cancer immunotherapy company, today announced t...

cel-sci-shares-are-trading-higher-after-the-company-announced-results-from-a-bias-analysis-conducted-for-its-concluded-phase-3-study-of-multikine-multikine-cut-the-5-year-risk-of-death-by-half-compared-to-control-in-its-target-population
CEL-SCI shares are trading higher after th...
07/26/2024 12:29:22

cel-scis-phase-3-population-analysis-for-confirmatory-registration-study-in-head--neck-cancer-demonstrates-well-balanced-patient-population-confidence-in-clinical-results-multikine-a-cancer-immunotherapy-cut-the-5-year-risk-of-death-by-half-compared-to-control-in-its-target-population
CEL-SCI's Phase 3 Population Analysis For ...
07/26/2024 12:24:33

Multikine, a true first-line cancer immunotherapy, cut the 5-year risk of death by half compared to control in its target popul...

cel-sci-appoints-robert-watson-as-chairperson-of-the-board
CEL-SCI Appoints Robert Watson As Chairper...
07/08/2024 13:21:33

CEL-SCI Corporation (NYSE:CVM) today announced that Robert ("Bob") Watson, who has served as a Director of the Company ...

cel-sci-presents-head--neck-cancer-data-at-iddst-annual-congress-in-budapest-risk-of-death-cut-in-half-for-patients-treated-with-multikine-in-the-target-population
CEL-SCI Presents Head & Neck Cancer Data A...
06/18/2024 12:21:27

Multikine significantly increases overall survival in patients with low levels of tumor cell PD-L1 expression in contrast to ap...

cel-sci-q2-2024-gaap-eps-028-misses-014-estimate
CEL-SCI Q2 2024 GAAP EPS $(0.28) Misses $(...
05/16/2024 13:06:11

CEL-SCI (AMEX:CVM) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.14) by 100...

12-health-care-stocks-moving-in-thursdays-pre-market-session
12 Health Care Stocks Moving In Thursday's...
05/09/2024 12:06:31

why-cel-sci-cvm-shares-are-trading-higher
Why CEL-SCI (CVM) Shares Are Trading Higher
05/08/2024 15:19:20

CEL-SCI shares are trading higher by 18.6% during Wednesday's session. The company received positive feedback from the FDA ...

cel-sci-shares-are-trading-higher-after-the-company-announced-it-received-fda-approval-for-its-confirmatory-study-of-multikine-for-the-treatment-of-head--neck-cancer
CEL-SCI shares are trading higher after th...
05/08/2024 15:19:02

cel-sci-receives-fda-approval-for-its-confirmatory-study-of-multikine-for-the-treatment-of-head--neck-cancer
CEL-SCI Receives FDA Approval For Its Conf...
05/08/2024 13:03:58

Critical milestone achieved—the FDA accepted CEL-SCI's selection criteria defining the Multikine target population before s...

12-health-care-stocks-moving-in-wednesdays-pre-market-session
12 Health Care Stocks Moving In Wednesday'...
05/08/2024 12:06:34

cel-sci-corporation-issues-letter-to-shareholders
CEL-SCI Corporation Issues Letter To Share...
03/06/2024 13:47:33

CEL-SCI Corporation (NYSE:CVM) today issued a letter to its shareholders. This letter will be sent to the Company's shareho...

cel-sci-q1-eps-014-up-from-018-yoy
CEL-SCI Q1 EPS $(0.14) Up From $(0.18) YoY
02/15/2024 13:12:43

CEL-SCI (AMEX:CVM) reported quarterly losses of $(0.14) per share. This is a 22.22 percent increase over losses of $(0.18) per ...

12-health-care-stocks-moving-in-fridays-intraday-session
12 Health Care Stocks Moving In Friday's I...
02/09/2024 17:31:35

why-cel-sci-corporation-cvm-shares-are-diving
Why CEL-SCI Corporation (CVM) Shares Are D...
02/09/2024 16:06:50

CEL-SCI Corporation shares are trading lower by 13.9% Friday morning. The company priced an offering of 3.875 million shares.

cel-sci-announces-pricing-of-775m-public-offering-of-3875m-shares-of-common-stock-at-200share
CEL-SCI Announces Pricing Of $7.75M Public...
02/09/2024 13:32:32

european-medicines-agency-grants-cel-sci-a-waiver-of-strict-pediatric-requirements-clearing-the-path-towards-marketing-authorization-for-multikine
European Medicines Agency Grants CEL-SCI A...
01/31/2024 14:18:40

CORE & Plaid

CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION